Mumbai: Hema CIPEF (I), an affiliate of the US-based Capital Group, is prone to promote a 0.9% stake in Mankind Pharma on Wednesday via block offers, in accordance with the time period sheet issued by bankers IIFL Securities and Kotak Securities. Hema CIPEF is providing to promote 37 lakh shares at a ground worth of Rs 2,061 per share, which is a 2% low cost to Tuesday’s closing worth of Rs 2,102.50 on the NSE. The deal on the ground worth is valued at Rs 763 crore.
Capital Group held a 2.22% stake within the firm as on March 31, 2024. In December final 12 months, Capital Group divested a 3.14% stake in Mankind Pharma.
Mankind Pharma launched its maiden public provide in April of final 12 months. The Rs 4,326-crore preliminary share sale of Mankind Pharma was subscribed 15.32 instances. The IPO was listed on Could 5 of final 12 months at a premium of 31% and has rallied 48% since then.
